| Study |
Reference |
|
AlSheikh (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2020
|
AlSheikh Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes. Neurosciences (Riyadh) 2020; 25:32-37
|
|
AlSheikh (Oxcarbazepine) (Controls unexposed, sick), 2020
|
AlSheikh Prevalence of epilepsy in Saudi pregnant women and possible effects of anti-epileptic drugs on pregnancy outcomes. Neurosciences (Riyadh) 2020; 25:32-37
|
|
Artama (Oxcarbazepine), 2005
|
Artama M Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005;64:1874-8
|
|
Artama (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2013
|
Artama M Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
|
|
Artama (Oxcarbazepine) (Controls unexposed, disease free), 2013
|
Artama M Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
|
|
Artama (Oxcarbazepine) (Controls unexposed, sick), 2013
|
Artama M Effects of maternal epilepsy and antiepileptic drug use during pregnancy on perinatal health in offspring: nationwide, retrospective cohort study in Finland. Drug Saf 2013;36:359-69
|
|
Aydin (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2020
|
Aydin, E. Retrospective evaluation of pregnancy outcomes with maternal epilepsy Journal of Clinical Obstetrics and Gynecology 2020; 30:20-.
|
|
Aydin (Oxcarbazepine) (Controls unexposed, sick), 2020
|
Aydin, E. Retrospective evaluation of pregnancy outcomes with maternal epilepsy Journal of Clinical Obstetrics and Gynecology 2020; 30:20-.
|
|
Battino, 2024
|
Battino Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol 2024; 81:481-489 Tomson Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 2018; 17:530-538 Tomson T Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17
|
|
Bjørk (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2022
|
Bjørk Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 2022; :
|
|
Bjørk (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2018
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168
|
|
Bjørk (Oxcarbazepine) (Controls unexposed NOS), 2022
|
Bjørk Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 2022; :
|
|
Bjørk (Oxcarbazepine) (Controls unexposed, disease free), 2018
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168
|
|
Bjørk (Oxcarbazepine) (Controls unexposed, sick), 2022
|
Bjørk Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 2022; :
|
|
Bjørk (Oxcarbazepine) (Controls unexposed, sick), 2018
|
Bjørk Association of Folic Acid Supplementation During Pregnancy With the Risk of Autistic Traits in Children Exposed to Antiepileptic Drugs In Utero. JAMA Neurol 2018; 75:160-168
|
|
Christensen (Oxcarbazepine) (Epilepsy) (Controls exposed to LTG), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849 Dreier Prenatal exposure to antiseizure medication and intrauterine growth restriction in offspring of women with epilepsy Epilepsia 2021; 62(S3):3-364.
|
|
Christensen (Oxcarbazepine) (Epilepsy) (Controls unexposed, general population), 2024
|
Christensen Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 2024; 38:100849 Dreier Prenatal exposure to antiseizure medication and intrauterine growth restriction in offspring of women with epilepsy Epilepsia 2021; 62(S3):3-364.
|
|
Cohen (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2019
|
Cohen Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry 2019; 80:
|
|
Cohen (Oxcarbazepine) (Controls unexposed NOS), 2019
|
Cohen Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. J Clin Psychiatry 2019; 80:
|
|
Cohen (Oxcarbazepine) (Epilepsy) (Controls exposed to LTG), 2023
|
Cohen Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. Ann Neurol 2023; 93:551-562
|
|
Cohen (Oxcarbazepine) (Epilepsy) (Controls unexposed, NOS), 2023
|
Cohen Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations. Ann Neurol 2023; 93:551-562
|
|
Coste (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2020
|
Blotière Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a French nationwide population-based cohort study. BMJ Open 2020; 10:e034829 Coste Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Sci Rep 2020; 10:17362
|
|
Coste (Oxcarbazepine) (Controls unexposed, NOS), 2020
|
Coste Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Sci Rep 2020; 10:17362
|
|
Dreier (Oxcarbazepine) (Epilepsy) (Controls exposed to LTG), 2023
|
Dreier Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. JAMA Neurol 2023; 80:568-577
|
|
Dreier (Oxcarbazepine) (Epilepsy) (Controls unexposed, sick), 2023
|
Dreier Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders. JAMA Neurol 2023; 80:568-577
|
|
Guveli, 2017
|
Guveli Teratogenicity of Antiepileptic Drugs. Clin Psychopharmacol Neurosci 2017; 15:19-27
|
|
Hao (Controls exposed to LTG), 2025
|
Hao Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study. Epilepsia 2025; :
|
|
Hao (Controls unexposed, sick), 2025
|
Hao Seizure control and pregnancy outcomes in Chinese women with epilepsy: A prospective multicenter cohort study. Epilepsia 2025; :
|
|
Hernández-Díaz (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2012
|
Hernández-Díaz Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9
|
|
Hernández-Díaz (Oxcarbazepine) (Controls unexposed, disease free), 2012
|
Hernández-Díaz Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9
|
|
Hosny (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2021
|
Hosny Risk factors of fetal deaths and major birth defects in newborns of women with epilepsy: An Egyptian prospective study. Epilepsy Behav 2021; 123:108251
|
|
Hosny (Oxcarbazepine) (Controls unexposed, sick), 2021
|
Hosny Risk factors of fetal deaths and major birth defects in newborns of women with epilepsy: An Egyptian prospective study. Epilepsy Behav 2021; 123:108251
|
|
Hvas (Oxcarbazepine) (Controls unexposed, disease free), 2000
|
Hvas CL Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000;107:896-902
|
|
Hvas (Oxcarbazepine) (Controls unexposed, sick), 2000
|
Hvas CL Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight. BJOG 2000;107:896-902
|
|
Kaaja (Oxcarbazepine), 2003
|
Kaaja E Major malformations in offspring of women with epilepsy. Neurology 2003;60:575-9
|
|
Kini (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2007
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.,Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20
|
|
Kini (Oxcarbazepine) (Controls unexposed, disease free), 2007
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.,Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20
|
|
Kini (Oxcarbazepine) (Controls unexposed, sick), 2007
|
Kini Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero.,Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero. Eur J Med Genet ; 50:411-20
|
|
Li (Oxcarbazepine) (Controls exposed to LTG), 2023
|
He Pregnancy outcome in women with epilepsy in Western China: A prospective hospital based study. Epilepsy Behav 2017; 74:10-14 Li Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China. Front Neurol 2023; 14:1195003
|
|
Li (Oxcarbazepine) (Controls unexposed, sick), 2023
|
He Pregnancy outcome in women with epilepsy in Western China: A prospective hospital based study. Epilepsy Behav 2017; 74:10-14 Li Pregnancy characteristics and adverse outcomes in offspring of women with epilepsy: a prospective registry study from Mainland China. Front Neurol 2023; 14:1195003
|
|
Meador (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2021
|
Meador Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. JAMA Neurol 2021; 78:927-936
|
|
Meador (Oxcarbazepine) (Controls unexposed, disease free), 2021
|
Meador Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. JAMA Neurol 2021; 78:927-936
|
|
Morrow (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2006
|
Morrow J Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
|
|
Morrow (Oxcarbazepine) (Controls unexposed, sick), 2006
|
Morrow J Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8
|
|
Razaz (Oxcarbazepine), 2024
|
Razaz Risk of Perinatal and Maternal Morbidity and Mortality Among Pregnant Women With Epilepsy. JAMA Neurol 2024; 81:985-995
|
|
Razaz (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2017
|
Razaz Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy. JAMA Neurol 2017; 74:983-991
|
|
Razaz (Oxcarbazepine) (Controls unexposed, disease free), 2017
|
Razaz Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy. JAMA Neurol 2017; 74:983-991
|
|
Razaz (Oxcarbazepine) (Controls unexposed, sick), 2017
|
Razaz Association Between Pregnancy and Perinatal Outcomes Among Women With Epilepsy. JAMA Neurol 2017; 74:983-991
|
|
Samrén (Oxcarbazepine), 1999
|
Samrén Antiepileptic drug regimens and major congenital abnormalities in the offspring.,Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann. Neurol. 1999; 46:739-46
|
|
Thomas (Controls exposed to LTG), 2022
|
Thomas, S.V. Differential impact of antenatal exposure to antiseizure medications on motor and mental development in infants of women with epilepsy Epileptic Disord. 2022; 24:531-.
|
|
Thomas (Controls unexposed, sick), 2022
|
Thomas, S.V. Differential impact of antenatal exposure to antiseizure medications on motor and mental development in infants of women with epilepsy Epileptic Disord. 2022; 24:531-.
|
|
Thomas (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2021
|
Keni Teratogenicity of antiepileptic dual therapy: Dose-dependent, drug-specific, or both? Neurology 2018; 90:e790-e796 Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281 Thomas Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021; 93:127-132
|
|
Thomas (Oxcarbazepine) (Controls unexposed, disease free), 2021
|
Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281
|
|
Thomas (Oxcarbazepine) (Controls unexposed, sick), 2021
|
Thomas Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Epilepsia 2017; 58:274-281 Thomas Malformation risk of new anti-epileptic drugs in women with epilepsy; observational data from the Kerala registry of epilepsy and pregnancy (KREP). Seizure 2021; 93:127-132
|
|
Tomson (Oxcarbazepine), 2015
|
Tomson T Antiepileptic drugs and intrauterine death: A prospective observational study from EURAP. Neurology 2015;85:580-8
|
|
Tomson (Oxcarbazepine), 2018
|
|
|
Trivedi (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2018
|
Trivedi Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India. Epilepsy Res 2018; 146:50-53
|
|
Trivedi (Oxcarbazepine) (Controls unexposed, sick), 2018
|
Trivedi Spontaneous fetal loss in women with epilepsy: prospective data from pregnancy registry in India. Epilepsy Res 2018; 146:50-53
|
|
Vajda a (Oxcarbazepine) (Controls exposed to LTG), 2024
|
Vajda Pregnancy, antiseizure medications and unexplained intrauterine foetal death. Epilepsy Behav 2024; 153:109724 Vajda Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand 2018; 137:20-23
|
|
Vajda a (Oxcarbazepine) (Controls unexposed sick), 2024
|
Vajda Pregnancy, antiseizure medications and unexplained intrauterine foetal death. Epilepsy Behav 2024; 153:109724 Vajda Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand 2018; 137:20-23
|
|
Vajda b (Oxcarbazepine) (Epilepsy) (Controls exposed to Lamotrigine, sick), 2024
|
Vajda Teratogenicity of the newer antiepileptic drugs--the Australian experience. J Clin Neurosci 2012; 19:57-9 Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130:234-8 Vajda The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy. Epilepsy Res 2024; 200:107316
|
|
Vajda b (Oxcarbazepine) (Epilepsy) (Controls unexposed, sick), 2024
|
Vajda Teratogenicity of the newer antiepileptic drugs--the Australian experience. J Clin Neurosci 2012; 19:57-9 Vajda Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010; 19:558-61 Vajda The prescribing of antiepileptic drugs for pregnant Australian women. Aust N Z J Obstet Gynaecol 2012; 52:49-53 Vajda Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013; 128:228-34 Vajda The teratogenic risk of antiepileptic drug polytherapy. Epilepsia 2010; 51:805-10 Vajda The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47:468-74 Vajda Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register. Seizure 2019; 65:6-11 Vajda The teratogenicity of the newer antiepileptic drugs - an update. Acta Neurol Scand 2014; 130:234-8 Vajda The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy. Epilepsy Res 2024; 200:107316
|
|
Veiby (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2014
|
Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Veiby (Oxcarbazepine) (Controls unexposed, disease free), 2014
|
Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Veiby (Oxcarbazepine) (Controls unexposed, sick), 2014
|
Veiby Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J. Neurol. 2014; 261:579-88
|
|
Videman (Oxcarbazepine) (Controls exposed to Lamotrigine, sick), 2016
|
Videman Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs. Epilepsy Behav 2016; 64:62-68
|
|
Videman (Oxcarbazepine) (Controls unexposed, disease free), 2016
|
Videman Evidence for spared attention to faces in 7-month-old infants after prenatal exposure to antiepileptic drugs. Epilepsy Behav 2016; 64:62-68
|
|
Viinikainen (Oxcarbazepine) (Controls unexposed, disease free) a, 2006
|
Viinikainen Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47:186-92
|
|
Viinikainen (Oxcarbazepine) (Controls unexposed, sick) a, 2006
|
Viinikainen Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Epilepsia 2006; 47:186-92
|
